The relationships between these biomarkers and the lung cancer microenvironment are complex and multifaceted; elevated CRP levels indicate systemic inflammation, which can create a proinflammatory environment within the tumor microenvironment, potentially promoting cancer cell survival and progression. The gene discussed is CRP; the disease is lung cancer.